Modeling PCDH19 clustering epilepsy by Neurogenin 2 induction of patient‐derived induced pluripotent stem cells
Epileptic Disorders · 2023
DOI: 10.1002/epd2.20065 ↗At a glance
Journal article in Epileptic Disorders, 2023. Written by Diana Alaverdian and 10 co-authors. Institution: Medical Genetics, University of Siena, Siena, Italy. Major MEDLINE topics: Induced Pluripotent Stem Cells, Epilepsy. Cited 8 times so far (Crossref); 45 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Ministero dell'Istruzione, dell'Università e della Ricerca, Ministero dell’Istruzione, dell’Università e della Ricerca.
Abstract (original language)
Background
Loss of function mutations in PCDH19 gene causes an X‐linked, infant‐onset clustering epilepsy, associated with intellectual disability and autistic features. The unique pattern of inheritance includes random X‐chromosome inactivation, which leads to pathological tissue mosaicism. Females carrying PCDH19 mutations are affected, while males have a normal phenotype. No cure is presently available for this disease.
Methods
Fibroblasts from a female patient carrying frameshift mutation were reprogrammed into human induced pluripotent stem cells (hiPSCs). To create a cell model of PCDH19‐clustering epilepsy (PCDH19‐CE) where both cell populations co‐exist, we created mosaic neurons by mixing wild‐type (WT) and mutated (mut) hiPSC clones, and differentiated them into mature neurons with overexpression of the transcriptional factor Neurogenin 2.
Results
We generated functional neurons from patient‐derived iPSC using a rapid and efficient method of differentiation through overexpression of Neurogenin 2. Was revealed an accelerated maturation and higher arborisation in the mutated neurons, while the mosaic neurons showed the highest frequency of action potential firing and hyperexcitability features, compared to mutated and WT neurons.
Conclusions
Our findings provide evidence that PCDH19 c.2133delG mutation affects proper metaphases with increased numbers of centrosomes in stem cells and accelerates neuronal maturation in premature cells. PCDH19 mosaic neurons showed elevated excitability, representing the situation in PCDH19‐CE brain. We suggest Ngn2 hiPSC‐derived PCDH19 neurons as an informative experimental tool for understanding the pathogenesis of PCDH19‐CE and a suitable approach for use in targeted drug screening strategies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Medical Genetics, University of Siena, Siena, Italy.
- Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
- Department of Experimental Medicine, Section of Physiology, University of Genoa, Genoa, Italy.
- IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
- Center for Synaptic Neuroscience and Technology, Istituto Italiano di Tecnologia, Genoa, Italy.
- Institute of Neuroscience, IN-CNR, Milan, Italy.
ORCID profiles: Diana Alaverdian
Funding
- Ministero dell'Istruzione, dell'Università e della Ricerca
- Ministero dell’Istruzione, dell’Università e della Ricerca
Cite
APA
Alaverdian, D., Corradi, A. M., Sterlini, B., Benfenati, F., Murru, L., Passafaro, M., Brunetti, J., Meloni, I., Mari, F., Renieri, A., & Frullanti, E. (2023). Modeling PCDH19 clustering epilepsy by Neurogenin 2 induction of patient‐derived induced pluripotent stem cells. Epileptic Disorders. https://doi.org/10.1002/epd2.20065
Vancouver
Alaverdian D, Corradi AM, Sterlini B, Benfenati F, Murru L, Passafaro M, et al. Modeling PCDH19 clustering epilepsy by Neurogenin 2 induction of patient‐derived induced pluripotent stem cells. Epileptic Disorders. 2023. doi:10.1002/epd2.20065
BibTeX
@article{Alaverdian2023,
author = {Alaverdian, Diana and Corradi, Anna Margherita and Sterlini, Bruno and Benfenati, Fabio and Murru, Luca and Passafaro, Maria and Brunetti, Jlenia and Meloni, Ilaria and Mari, Francesca and Renieri, Alessandra and Frullanti, Elisa},
title = {Modeling PCDH19 clustering epilepsy by Neurogenin 2 induction of patient‐derived induced pluripotent stem cells},
journal = {Epileptic Disorders},
year = {2023},
doi = {10.1002/epd2.20065}
}
EUVIMED